New Judicial Directive Targets Unethical Drug Marketing Practices
In a landmark judgment delivered on October 8, the Supreme Court ordered the Centre to create a specialist committee aimed at eliminating unethical promotional tactics used by pharmaceutical companies. The move follows a petition that highlighted how doctors receive luxurious gifts, foreign travel, cash incentives and other benefits that sway prescribing habits toward expensive or non‑essential drugs.
The petitioners argued that such inducements compromise medical judgment and inflate healthcare costs for ordinary citizens. While the government previously sought additional time to formulate a policy draft, the court emphasized the urgency of the matter and mandated immediate action.
The newly formed committee will examine current marketing norms, propose statutory provisions to ban lavish gifts, and recommend monitoring mechanisms. It will also solicit feedback from patients, medical professionals and civil society organisations before presenting its final recommendations to the Union Government.
A follow‑up hearing is scheduled for January 29, where the government must submit an affidavit outlining the steps taken to establish the committee and progress on drafting the necessary regulations.